EA201491272A1 - Нанопродукт, содержащий lactobacillus reuteri dan080, подходящий для профилактики и терапии - человеческой и ветеринарной, и его медицинское применение - Google Patents
Нанопродукт, содержащий lactobacillus reuteri dan080, подходящий для профилактики и терапии - человеческой и ветеринарной, и его медицинское применениеInfo
- Publication number
- EA201491272A1 EA201491272A1 EA201491272A EA201491272A EA201491272A1 EA 201491272 A1 EA201491272 A1 EA 201491272A1 EA 201491272 A EA201491272 A EA 201491272A EA 201491272 A EA201491272 A EA 201491272A EA 201491272 A1 EA201491272 A1 EA 201491272A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- lactobacillus reuteri
- nanoproduct
- human
- reuteri dan080
- veterinary
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/36—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62C—FIRE-FIGHTING
- A62C2/00—Fire prevention or containment
- A62C2/06—Physical fire-barriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/10—Materials for lubricating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Emergency Management (AREA)
- Business, Economics & Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
Abstract
Изобретение относится к нанопродукту, подходящему для профилактики и терапии - человеческой и ветеринарной, а также к медицинскому применению указанного нанопродукта. В заявке раскрыт штамм Lactobacillus reuteri DAN080, депонированный под номером DSM 15693, для применения в медицине. Предложены различные формы препаратов, содержащих штамм Lactobacillus reuteri DAN080, депонированный под номером DSM 15693, для применения в медицине в качестве терапевтического и профилактического агента, особенно в качестве противомикробного агента, в профилактике и лечении состояний, развивающихся в результате инфекций, вызванных бактериями, грибами и другими патогенами желудочно-кишечного тракта, поверхности тела и других систем, таких как мочеполовая система, дыхательная система, у позвоночных или в качестве терапевтического и/или профилактического агента для лечения и предотвращения развития подагры и/или для увеличения активности лизоцима в организме позвоночного, особенно человека, другого млекопитающего или птицы. Также предложены медицинские инструменты, такие как катетеры и гигиенические изделия, содержащие продукты культур штамма Lactobacillus reuteri DAN080, депонированного под номером DSM 15693.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/PL2012/000039 WO2013180585A1 (en) | 2012-05-29 | 2012-05-29 | Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201491272A1 true EA201491272A1 (ru) | 2015-10-30 |
Family
ID=46551832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201491272A EA201491272A1 (ru) | 2012-05-29 | 2012-05-29 | Нанопродукт, содержащий lactobacillus reuteri dan080, подходящий для профилактики и терапии - человеческой и ветеринарной, и его медицинское применение |
Country Status (7)
Country | Link |
---|---|
US (1) | US20160032413A1 (ru) |
JP (1) | JP2015520773A (ru) |
KR (1) | KR20150027152A (ru) |
CN (1) | CN104684565A (ru) |
EA (1) | EA201491272A1 (ru) |
IN (1) | IN2014MN02444A (ru) |
WO (1) | WO2013180585A1 (ru) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI719691B (zh) * | 2019-10-28 | 2021-02-21 | 葡萄王生技股份有限公司 | 羅伊氏乳桿菌(Lactobacillus reuteri)菌株GKR1用於製備降低尿酸之組成物的用途 |
US20220370688A1 (en) * | 2019-10-28 | 2022-11-24 | Hollister Incorporated | Urinary catheters and methods for preventing bacterial infections |
KR102136522B1 (ko) * | 2020-03-04 | 2020-07-22 | 주식회사 락토메이슨 | 안전성 및 장부착능이 우수한 모유유래 락토바실러스 루테리 lm1071 균주, 및 상기 균주 또는 이의 배양물을 포함하는 조성물 |
CN111849827B (zh) * | 2020-07-31 | 2022-02-11 | 南京农业大学 | 犬源产维生素b12乳酸菌及应用 |
CN114196581B (zh) * | 2020-12-16 | 2023-06-13 | 江南大学 | 缓解高尿酸血症的罗伊氏乳杆菌ccfm1132及应用 |
KR102660672B1 (ko) * | 2021-08-25 | 2024-04-26 | 한국생명공학연구원 | 항균 활성 및 프로바이오틱스 특성을 가진 락토바실러스 루테리 br301 균주 및 이의 용도 |
KR20230131450A (ko) * | 2022-03-03 | 2023-09-13 | 한국생명공학연구원 | N-카바밀-l-글루탐산을 포함하는 염증성 질환의 치료용 조성물 |
CN118126909A (zh) * | 2024-05-10 | 2024-06-04 | 善恩康生物科技(苏州)有限公司 | 一种罗伊氏乳杆菌及其在抗幽门螺杆菌中的应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988008450A1 (en) | 1987-05-01 | 1988-11-03 | Birdwell Finlayson | Gene therapy for metabolite disorders |
JP3007092B2 (ja) * | 1987-05-01 | 2000-02-07 | バイオガイア・バイオロジクス・エイビー | 抗生物質レウテリン |
US5019096A (en) * | 1988-02-11 | 1991-05-28 | Trustees Of Columbia University In The City Of New York | Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same |
WO1989011294A1 (en) | 1988-05-26 | 1989-11-30 | Nika Health Care, Inc. | Antiviral or antibacterial compound and method of use |
US5837238A (en) * | 1996-06-05 | 1998-11-17 | Biogaia Biologics Ab | Treatment of diarrhea |
CA2374938A1 (en) * | 1999-05-25 | 2000-11-30 | Gregor Reid | Lactobacillus compositions and methods for preventing wound infections and biofilm formation on implantable surgical devices |
WO2001052667A2 (en) * | 2000-01-18 | 2001-07-26 | Societe Des Produits Nestle S.A. | Pet food composition for treating helicobacter species in pets |
US7105336B2 (en) * | 2002-10-07 | 2006-09-12 | Biogaia Ab | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
WO2005021575A2 (en) * | 2003-08-29 | 2005-03-10 | Gregor Reid | Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties |
JP2006257077A (ja) * | 2005-02-18 | 2006-09-28 | Marudai Food Co Ltd | 免疫調節剤および免疫調節食品 |
PL226695B1 (pl) | 2006-07-03 | 2017-08-31 | Danuta Kruszewska | Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori |
EP2221359B1 (en) * | 2007-11-29 | 2014-01-15 | Meiji Co., Ltd. | Lactic acid bacteria having action of lowering blood uric acid level |
US20110293710A1 (en) * | 2010-02-02 | 2011-12-01 | Delphine Saulnier | Immunomodulatory properties of lactobacillus strains |
EP2457576B1 (en) * | 2010-11-29 | 2020-07-08 | Eurochit Danuta Kruszewska | Lactobacillus reuteri strain for use in the medical and veterinary prophylaxis and treatment of metabolic syndrome or infections |
HUE027565T2 (en) * | 2010-11-29 | 2016-10-28 | Eurochit Danuta Kruszewska | New procedure for the production of Lactobacillus reuteri strain for medical and veterinary prevention and treatment |
HUE033223T2 (hu) * | 2010-11-29 | 2017-11-28 | Eurochit Danuta Kruszewska | Új nanotermék kórmegelõzésben, diagnosztikában, valamint orvosi és állatorvosi kezelésben való alkalmazásra |
CN102304489B (zh) * | 2011-09-23 | 2013-06-12 | 北京龙科方舟生物工程技术有限公司 | 一株罗伊氏乳杆菌及其应用 |
-
2012
- 2012-05-29 EA EA201491272A patent/EA201491272A1/ru unknown
- 2012-05-29 CN CN201280074571.9A patent/CN104684565A/zh active Pending
- 2012-05-29 JP JP2015514949A patent/JP2015520773A/ja active Pending
- 2012-05-29 KR KR1020147036830A patent/KR20150027152A/ko active IP Right Grant
- 2012-05-29 WO PCT/PL2012/000039 patent/WO2013180585A1/en active Application Filing
- 2012-05-29 US US14/404,793 patent/US20160032413A1/en not_active Abandoned
-
2014
- 2014-12-01 IN IN2444MUN2014 patent/IN2014MN02444A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20160032413A1 (en) | 2016-02-04 |
IN2014MN02444A (ru) | 2015-07-10 |
JP2015520773A (ja) | 2015-07-23 |
WO2013180585A1 (en) | 2013-12-05 |
CN104684565A (zh) | 2015-06-03 |
KR20150027152A (ko) | 2015-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201491272A1 (ru) | Нанопродукт, содержащий lactobacillus reuteri dan080, подходящий для профилактики и терапии - человеческой и ветеринарной, и его медицинское применение | |
CY1122191T1 (el) | Βακτηριο για χρηση ως προβιοτικο για διατροφικες και ιατρικες εφαρμογες | |
MX2012012345A (es) | Metodo de reduccion de biopeliculas. | |
EA201490512A1 (ru) | Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека | |
UA109876C2 (ru) | Композиция, содержащая bifidobacterium longum cncm i-2 618, для профилактики и лечения иммунных расстройств | |
BRPI1011277B8 (pt) | produto de bacteriocina lactobacillus pentosus, alimento e composições farmacêuticas contendo o mesmo e uso do mesmo | |
WO2010023207A3 (en) | Antimicrobial agents | |
MX2013000876A (es) | Dihidroxi-clorinas glico-sustituidas y clorinas beta-funcionalizadas para terapia fotodinamica anti-microbiana. | |
Choi et al. | The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) | |
PH12020551905A1 (en) | C-mannoside compounds useful for the treatment of urinary tract infections | |
ZA202002093B (en) | Antibacterial compounds | |
MX2019005751A (es) | Tratamiento de enfermedades e infecciones de las vias respiratorias con composiciones de acido ascorbico. | |
Ercan et al. | Inhibition of biofilms by non-thermal plasma treated novel solutions | |
WO2010125196A3 (en) | Bacteriophages specific to pak and cha strains of pseudomonas aeruginosa and their applications | |
EA201390487A1 (ru) | Антимикробный белок | |
BR112015027636A2 (pt) | Uso da composição farmacêutica | |
BR112017022463A2 (pt) | tratamento de infecções bacterianas em aquacultura | |
GB2546439A (en) | Ezrin-derived peptides and pharmaceutical compositions thereof | |
MX2019002657A (es) | Combinaciones con un peptido con esqueleto ciclado. | |
MX2019002894A (es) | Combinaciones con un peptido ciclado con la estructura de la base. | |
WO2015100448A3 (en) | Multimodal antimicrobial therapy | |
MX2019006086A (es) | Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados. | |
MX2019002386A (es) | Uso de oligosacaridos de leche humana en el engorde de terneros. | |
MY170190A (en) | Use of a fermented soy extract as a prebiotic composition | |
WO2016072854A3 (en) | Pantothenamide analogues |